Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 150
Filter
1.
Neuroscience ; 116(1): 275-83, 2003.
Article in English | MEDLINE | ID: mdl-12535959

ABSTRACT

Single exposure to the proinflammatory cytokine interleukin-1 induces sensitization of the adrenocorticotropin hormone and corticosterone responses to stressors weeks later (hypothalamus-pituitary-adrenal sensitization). Hypothalamus-pituitary-adrenal responses are controlled by corticotropin-releasing hormone and arginine-vasopressin secreted from parvocellular corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus and may involve autoexcitatory feedback mechanisms. Therefore, we studied the temporal relationship between resting levels of corticotropin-releasing hormone, corticotropin-releasing hormone-R1 and arginine-vasopressin receptor (V1a, V1b) mRNAs in the paraventricular nucleus and the development of hypothalamus-pituitary-adrenal sensitization to an emotional stressor (novelty). The adrenocorticotropin hormone precursor molecule proopiomelanocortin hnRNA in the pituitary gland served as an index for acute activation. Single administration of interleukin-1 induced sensitization of the hypothalamus-pituitary-adrenal to novelty from 3 to 22 days later, but not after 42 days. Single administration of interleukin-1 induced biphasic increases in corticotropin-releasing hormone and corticotropin-releasing hormone-R1 mRNAs in the paraventricular nucleus: an early peak within 24 h, followed by a delayed (>7 days) increase that peaked after 22 days. Hypothalamic V1a and V1b mRNA levels were unaffected. In contrast, in the pituitary gland, there was an early decrease in corticotropin-releasing hormone-R1 mRNA (from 10.5 to 3 h after interleukin-1) and V1b receptor mRNA (3 to 6 h), which returned to control levels from 24 h onwards. Thus, interleukin-1-induced long-lasting hypothalamus-pituitary-adrenal sensitizations associated with prolonged activation of corticotropin-releasing hormone and corticotropin-releasing hormone-R1 mRNA expression in the paraventricular nucleus, but not with changes in the expression of proopiomelanocortin hnRNA or V1b receptor or corticotropin-releasing hormone R1 mRNAs in the pituitary gland. We propose that transient exposure to immune events can induce long-lasting hypothalamus-pituitary-adrenal sensitization, which at least in part involves long-term hypothalamic adaptations that enhance central corticotropin-releasing hormone signaling.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Interleukin-1/administration & dosage , Interleukin-1/metabolism , Paraventricular Hypothalamic Nucleus/drug effects , Paraventricular Hypothalamic Nucleus/metabolism , RNA, Messenger/metabolism , Receptors, Corticotropin-Releasing Hormone/metabolism , Receptors, Vasopressin/metabolism , Stress, Psychological/metabolism , Adrenocorticotropic Hormone/blood , Adrenocorticotropic Hormone/drug effects , Animals , Corticosterone/blood , Corticotropin-Releasing Hormone/drug effects , In Situ Hybridization , Male , Pituitary Gland/drug effects , Pituitary Gland/metabolism , Pro-Opiomelanocortin/metabolism , RNA, Messenger/drug effects , Radioimmunoassay , Rats , Rats, Wistar , Receptors, Corticotropin-Releasing Hormone/drug effects , Receptors, Vasopressin/drug effects , Time Factors
2.
J Neuroimmunol ; 118(2): 203-11, 2001 Aug 30.
Article in English | MEDLINE | ID: mdl-11498255

ABSTRACT

The expression of interleukin-1beta was examined in dorsal root ganglion (DRG) neurons from adult rats using non-radioactive in situ hybridization and immunocytochemistry. At all spinal levels, approximately 70% of the DRG neurons appeared to express IL-1beta mRNA; about 80% of these DRG neurons actually appeared to produce the IL-1beta protein at markedly varying levels. The expression of IL-1beta was found in large as well as in intermediate diameter sensory neurons but only sporadically in the population of small sensory neurons. The population of IL-1beta immunopositive sensory neurons included most of the large calretinin-positive Ia afferents, but only a few of the small substance P/CGRP positive sensory neurons. In situ hybridization staining for the detection of type 1 IL-1 receptor showed expression of this receptor by most of the sensory neurons as well as by supportive glial-like cells, presumably satellite cells. The functional significance of IL-1beta in the DRG neurons needs to be elucidated, but we speculate that IL-1beta produced by DRG neurons may be an auto/paracrine signalling molecule in sensory transmission.


Subject(s)
Ganglia, Spinal/metabolism , Interleukin-1/biosynthesis , Neurons, Afferent/metabolism , Animals , Calbindin 2 , Calcitonin Gene-Related Peptide/biosynthesis , Cell Size , Cytoplasm/metabolism , Cytoplasm/ultrastructure , Female , Ganglia, Spinal/cytology , Immunohistochemistry , In Situ Hybridization , Interleukin-1/genetics , Male , Microscopy, Immunoelectron , Neuroglia/cytology , Neuroglia/metabolism , Neurons, Afferent/cytology , Polyribosomes/metabolism , Polyribosomes/ultrastructure , RNA, Messenger/biosynthesis , Rats , Receptors, Interleukin-1/biosynthesis , Receptors, Interleukin-1 Type I , S100 Calcium Binding Protein G/biosynthesis , Substance P/biosynthesis
3.
Endocrinology ; 142(8): 3616-24, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11459810

ABSTRACT

In this study, we demonstrate that disruption of neuroendocrine signaling is a major factor driving disease progression in myelin oligodendrocyte glycoprotein-induced chronic relapsing experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Although the initial episode of chronic relapsing experimental autoimmune encephalomyelitis is associated with a robust hypothalamic-pituitary-adrenocortical axis response, we show that subsequent disease progression is associated with a selective desensitization of hypothalamic-pituitary-adrenocortical responsiveness to inflammatory mediators. Inflammatory activity in the central nervous system during relapse is therefore unable to produce an endogenous immunosuppressive corticosterone response, and disease progresses into an ultimately lethal phase. However, disease progression is inhibited if the circulating corticosterone level is maintained at levels seen during the initial phase of disease. The effect of hypothalamic-pituitary-adrenocortical axis desensitization on the clinical course of experimental autoimmune encephalomyelitis is aggravated by a marked reduction in proinflammatory cytokine synthesis in the central nervous system in the later stages of disease, reflecting an increasing involvement of antibody, rather than T cell-dependent effector mechanisms, in disease pathogenesis, with time. Thus, our data indicate that distinct immune-endocrine effects play a decisive role in determining disease progression in multiple sclerosis, a concept supported by reports that a subpopulation of multiple sclerosis patients shows evidence of hypothalamic-pituitary-adrenocortical axis desensitization.


Subject(s)
Corticosterone/antagonists & inhibitors , Encephalomyelitis, Autoimmune, Experimental/physiopathology , Animals , Autoantibodies/analysis , Chronic Disease , Corticosterone/pharmacology , Cytokines/metabolism , Disease Progression , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Hypothalamo-Hypophyseal System/physiopathology , Inflammation Mediators/metabolism , Myelin Proteins , Myelin-Associated Glycoprotein/immunology , Myelin-Oligodendrocyte Glycoprotein , Pituitary-Adrenal System/physiopathology , Rats , Rats, Inbred Strains , Receptors, Steroid/metabolism , Recurrence , Remission Induction , Spinal Cord/metabolism , Spinal Cord/pathology , Time Factors
4.
Eur J Neurosci ; 13(10): 1923-30, 2001 May.
Article in English | MEDLINE | ID: mdl-11403685

ABSTRACT

Single administration of the cytokine interleukin-1beta (IL-1) or the psychostimulant amphetamine causes long-term sensitization of the hypothalamus pituitary adrenal (HPA) axis, i.e. enhanced adrenocorticotropine hormone (ACTH) and corticosterone responses weeks later. HPA responses to these stimuli involve activation of hypothalamic corticotropin-releasing hormone (CRH) neurons by noradrenergic projections to the paraventricular nucleus (PVN). In search of the underlying mechanisms, we studied the temporal pattern of HPA sensitization in relation to (1) the reactivity of noradrenergic projections to the PVN and (2) altered secretagogue production in hypothalamic CRH neurons. Single exposure to IL-1 or amphetamine induced cross-sensitization of ACTH and corticosterone responses 11 and 22 days later, but not after 42 days. Amphetamine-induced HPA sensitization was not accompanied by increased costorage of arginine vasopressin (AVP) in CRH terminals, as found previously after IL-1 pretreatment. The reactivity of noradrenergic terminals was assessed by measuring the electrically evoked release of [3H]-noradrenaline from superfused PVN slices. Single administration of amphetamine and IL-1 induced a long-lasting (up to 22 days) increase (up to 165%) of evoked noradrenaline release. This indicates that single exposure to psychostimulants or to cytokines can induce a long-lasting increase in stimulus-secretion coupling in brainstem noradrenergic neurons that innervate the PVN. This common, long-lasting functional change may underlie, at least in part, IL-1- and amphetamine-induced HPA cross-sensitization. In addition, increased AVP signalling by hypothalamic CRH neurons appears to play a role in IL-1-induced, but not in amphetamine-induced, HPA sensitization.


Subject(s)
Adrenocorticotropic Hormone/pharmacology , Amphetamine/pharmacology , Central Nervous System Stimulants/pharmacology , Corticosterone/pharmacology , Hypothalamus/drug effects , Hypothalamus/metabolism , Interleukin-1/pharmacology , Norepinephrine/metabolism , Animals , Arginine Vasopressin/metabolism , Corticotropin-Releasing Hormone/metabolism , Drug Resistance , Exploratory Behavior/drug effects , Hypothalamo-Hypophyseal System/drug effects , Male , Median Eminence/metabolism , Rats , Rats, Wistar , Stress, Psychological/psychology , Time Factors
5.
Alcohol Clin Exp Res ; 25(1): 98-105, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11198721

ABSTRACT

BACKGROUND: Prior (3-12 days) injection of alcohol significantly blunts the response of the hypothalamic-pituitary-adrenal (HPA) axis to a second drug challenge without measurably altering responses to other stressors. We therefore determined whether adaptation in hypothalamic neurons underlies this decreased activity. METHODS: Adult male rats were administered alcohol (4.5 g/kg intragastrically) or vehicle daily for three consecutive days and then were challenged with the vehicle or alcohol 7 days later. Levels of adrenocorticotropin hormone (ACTH) in the circulation, corticotropin-releasing factor (CRF), CRF receptors type 1 (CRFR1) and vasopressin (VP) transcripts in the paraventricular nucleus (PVN) of the hypothalamus, and CRF/VP peptide in the median eminence were measured. RESULTS: Resting PVN levels of CRF, CRFR1, and VP were comparable in all animals on day 7 of recovery, whereas CRF and VP stores in the external zone of the median eminence were decreased in animals previously exposed to alcohol. After the acute alcohol challenge on day 7, rats previously exposed to the drug exhibited a significant (p < 0.01) dampening of their PVN CRF and CRFR1, but not VP neuronal response, compared with vehicle-pretreated rats. CONCLUSION: Blunted neuronal activity of PVN CRF neurons may be responsible for the decreased ACTH response that we previously reported in rats that had been injected with alcohol several days earlier. In addition, and despite comparable PVN VP transcript levels, the lower levels of this peptide in the median eminence also may participate in the blunted ACTH response that we observed.


Subject(s)
Adrenocorticotropic Hormone/drug effects , Central Nervous System Depressants/pharmacology , Corticotropin-Releasing Hormone/drug effects , Ethanol/pharmacology , Paraventricular Hypothalamic Nucleus/drug effects , Vasopressins/drug effects , Adrenocorticotropic Hormone/metabolism , Animals , Corticotropin-Releasing Hormone/metabolism , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/metabolism , Male , Paraventricular Hypothalamic Nucleus/metabolism , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Corticotropin-Releasing Hormone/drug effects , Receptors, Corticotropin-Releasing Hormone/metabolism , Vasopressins/metabolism
6.
J Neuroendocrinol ; 13(1): 74-85, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11123517

ABSTRACT

In lactating female rats, tonically elevated glucocorticoid secretion is accompanied by blunted stress responsiveness, reduced expression of hypothalamic corticotropin-releasing factor (CRF) mRNA and modest increases in arginine vasopressin (AVP) expression in the paraventricular nucleus (PVN). To determine the relative contribution of CRF and AVP to parvocellular function, we performed selective CRF (CRF-Tx) or AVP (AVP-Tx) lesions in the PVN neurones of ovariectomized virgin or lactating females (day 2 of lactation) by using ricin A associated with monoclonal antibodies directed towards CRF or AVP. We also performed double immunohistochemical labelling of CRF and AVP in the PVN of control rats injected with immunoglobulin (Ig)Gs associated with the ricin A (IgG-Tx). Brains were collected 12 days after the lesion and processed for in situ hybridization of CRF and AVP mRNA or for double fluorescence CRF and AVP immunohistochemistry. We found that lactating females exhibit a high degree of CRF and AVP colocalization in parvocellular PVN neurones, hypothalamic processes and median eminence terminals compared to virgins. While CRF mRNA is significantly reduced in lactating rats, AVP mRNA and protein levels are greatly enhanced in parvocellular PVN neurones during lactation. Hypothalamic CRF or AVP ricin-A lesions significantly reduced both CRF and AVP expression (15-35% decrease) as well as peptide immunoreactivity in PVN neurones in both groups of females. The specificity of the lesions varied between virgins and lactators since in virgin females, AVP-Tx did not affect CRF mRNA expression whereas in lactating females, this same lesion significantly reduced CRF mRNA expression, suggesting that parvocellular PVN neurones are more sensitive to the effects of the lesions during lactation. In both virgins and lactators, lesion with CRF-Tx tended to increase AVP mRNA expression; however, in virgins, parvocellular PVN neurones were possibly compensating for the loss of CRF synthesis by increasing AVP expression and immunoreactivity. We conclude that lactation is associated with a high degree of CRF and AVP colocalization in parvoPVN neurones and that the increased AVP production in these neurones increases their sensitivity to immunotargeted lesions. The opposite regulation of CRF and AVP gene expression during lactation might provide a useful model to study differential sensitivity to glucocorticoid feedback or hypothalamic activation of transcription factors.


Subject(s)
Arginine Vasopressin/metabolism , Corticotropin-Releasing Hormone/metabolism , Lactation/physiology , Paraventricular Hypothalamic Nucleus/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Arginine Vasopressin/genetics , Arginine Vasopressin/immunology , Corticotropin-Releasing Hormone/genetics , Corticotropin-Releasing Hormone/immunology , Female , Gene Expression/physiology , Immunohistochemistry , Median Eminence/chemistry , Median Eminence/cytology , Median Eminence/metabolism , Neurons/chemistry , Neurons/metabolism , Ovariectomy , Paraventricular Hypothalamic Nucleus/chemistry , Paraventricular Hypothalamic Nucleus/cytology , Pregnancy , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Ricin
7.
J Neuropathol Exp Neurol ; 60(12): 1208-18, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11764093

ABSTRACT

Demyelinating lesions of fiber bundles in and adjacent to the hypothalamus (i.e. the fornix. anterior commissure, internal capsule, and optic system) may be the basis for autonomic and endocrine alterations in multiple sclerosis (MS) patients. Therefore we investigated the presence and immunological activity of lesions in hypothalamic fiber bundles of 17 MS patients and 14 controls. In the MS group, 16 of 17 patients showed demyelinated lesions. The incidence of active lesions was high (60%) and outnumbered chronic inactive lesions in the internal capsule (p = 0.005). In 4 of 17 MS patients, axonal damage was observed and in 3 of 17 MS patients grey matter lesions were apparent. Duration of MS was inversely related to the active hypothalamic MS lesion score (r = -0.72, p = 0.001). Since comparison of hypothalamic lesions with MS lesions in other areas of the brain in the same patients (n = 7) showed a great similarity both as stage and appearance was concerned, this negative relation in all likelihood reflects the clinical consequences of high disease activity throughout the whole brain. In controls no demyelinating lesions were seen but in 11 control cases HLA expression was observed that was lower than that present in MS patients (p = 0.02). In the median eminence region that lacks a blood-brain barrier, all controls showed a strong HLA expression around the blood vessels. We conclude that systematic pathological investigation of the hypothalamus in MS patients reveals an unexpected high incidence of active lesions that may impact on hypothalamic functioning.


Subject(s)
Hypothalamus/pathology , Multiple Sclerosis/pathology , Adult , Aged , Aged, 80 and over , Axons/pathology , Chi-Square Distribution , Demyelinating Diseases/pathology , Disease Progression , Female , Humans , Male , Median Eminence/pathology , Middle Aged , Nerve Fibers, Myelinated/pathology , Severity of Illness Index , Statistics, Nonparametric
8.
J Neuroendocrinol ; 12(12): 1186-93, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11106976

ABSTRACT

Lewis rats exhibit multiple defects in their hypothalamus-pituitary-adrenal (HPA) system that are considered to play a causal role in the susceptibility of this strain to autoimmune diseases, i.e. experimental allergic encephalomyelitis (EAE). In the present study, we aimed to modulate the HPA response of the Lewis rat and establish its consequences for the susceptibility to EAE. Because in Wistar rats, single administration of interleukin (IL)-beta (priming) is known to induce long-lasting (weeks) sensitization of HPA responses to stressors and immune stimuli, Lewis rats were given a single dose of hIL-1beta or vehicle 1 week prior to induction of EAE by immunization with myelin basic protein (MBP). Subsequently, neurological deficits were monitored once daily. The results show that IL-1 priming markedly suppresses the neurological symptoms of EAE, without affecting the onset or duration of the disease. Measurement of vasopressin and corticotropin releasing hormone (CRH) in the external zone of the median eminence revealed that, as compared to Wistar rats, Lewis rats exhibit low vasopressin but identical CRH, and that IL-1 priming increases (0.001) vasopressin without affecting CRH stores, which is consistent with a shift to vasopressin-dominated control of adrenocorticotropic hormone (ACTH) secretion as described in Wistar rats under conditions of HPA hyper(re)activity. However, IL-1 priming did not affect a.m. corticosterone levels following immunization with MBP or during the clinical phase of EAE. IL-1 priming of Lewis rats attenuated the ACTH responses to an IL-1 challenge 11 days later, which may relate to an increase in resting corticosterone levels. Thus, the mechanisms underlying IL-1 induced suppression of EAE are not related to enhanced HPA responses. In addition, we did not find IL-1 priming-induced alterations in MBP-specific immunoglobulin (Ig)M, IgG1, IgGa and IgGb plasma titres, or gross alterations in T cell activation as reflected in spontaneous or concanavalin-induced T cell proliferation. We therefore speculate that IL-1-induced elevation of resting corticosterone levels may influence the development of EAE.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/immunology , Interleukin-1/pharmacology , Adrenocorticotropic Hormone/blood , Animals , Cell Division/drug effects , Cell Division/immunology , Concanavalin A/pharmacology , Corticosterone/blood , Corticotropin-Releasing Hormone/analysis , Corticotropin-Releasing Hormone/immunology , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Immunization , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Median Eminence/chemistry , Median Eminence/drug effects , Median Eminence/immunology , Myelin Basic Protein/immunology , Myelin Basic Protein/pharmacology , Neurologic Examination , Rats , Rats, Inbred Lew , Rats, Wistar , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Vasopressins/analysis , Vasopressins/immunology
9.
Neurosci Lett ; 285(3): 169-72, 2000 May 19.
Article in English | MEDLINE | ID: mdl-10806313

ABSTRACT

In the present study, we examined whether the vagus nerve is involved in mediating lipopolysaccharide (LPS)-induced appearance of IL-1beta immunoreactive cells in the brain and pituitary gland. Rats were either sham-operated or subjected to subdiaphragmatic vagotomy. Four weeks later, pyrogen free saline or 400 microg/kg LPS was administered to the rats intraperitoneally. Four and 8 h later, the animals were intracardially perfused with 4% paraformaldehyde and tissues were prepared for IL-1beta immunocytochemistry. IL-1beta positive cells were observed at both time-intervals after LPS administration in the choroid plexus, meninges, circumventricular organs and pituitary gland of both sham-operated and vagotomized rats. We conclude that under the conditions studied, the vagus nerve does not mediate LPS-induced appearance of IL-1beta in the rat brain and pituitary gland.


Subject(s)
Brain/metabolism , Interleukin-1/metabolism , Pituitary Gland/metabolism , Vagus Nerve/physiology , Animals , Brain/drug effects , Lipopolysaccharides/pharmacology , Male , Pituitary Gland/drug effects , Rats , Rats, Sprague-Dawley , Vagotomy , Vagus Nerve/drug effects
10.
Glia ; 30(2): 134-42, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10719355

ABSTRACT

The pro-inflammatory cytokines interleukin-1beta (IL-1beta), IL-6, tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO) can be produced by activated glial cells and play a critical role in various neurological diseases. Using primary co-cultures of rat microglial and astroglial cells, we investigated the effects of the anti-inflammatory cytokines transforming growth factor-beta1 (TGF-beta1)/beta2, IL-4, and IL-10 on the production of (pro-) inflammatory mediators after stimulation of the cells with lipopolysaccharide (LPS; 0.1 micrograms/ml, 24 h). IL-10 (10 and 100 ng/ml) and IL-4 (5 and 50 U/ml) suppressed the LPS-induced production of NO, IL-6, and TNF-alpha in a dose-dependent manner, whereas TGF-beta1/beta2 (2 and 20 ng/ml) only suppressed NO production. LPS-induced levels of IL-1beta were suppressed by IL-10, but not by IL-4 and TGF-beta1/beta2. Conversely, co-incubation of the glial cells with LPS and antibodies to TGF-beta1/beta2 selectively enhanced LPS-induced NO production, whereas co-incubation with antibody to IL-10 enhanced LPS-induced production of all pro-inflammatory cytokines and NO. This finding strongly suggests that effective concentrations of TGF-beta1/beta2 and IL-10 are produced by LPS-stimulated glial cell co-cultures. Production of IL-10 in these co-cultures was confirmed by measurement of rat IL-10 by radioimmunoassay. We conclude that anti-inflammatory cytokines affect the production of inflammatory mediators in LPS-activated co-cultures of microglial and astroglial cells differentially.


Subject(s)
Astrocytes/metabolism , Cytokines/biosynthesis , Interleukin-10/pharmacology , Interleukin-4/pharmacology , Microglia/metabolism , Nitric Oxide/biosynthesis , Transforming Growth Factor beta/pharmacology , Animals , Antibodies/pharmacology , Astrocytes/cytology , Astrocytes/drug effects , Cells, Cultured , Interleukin-1/biosynthesis , Interleukin-1/immunology , Interleukin-10/immunology , Interleukin-10/metabolism , Interleukin-4/immunology , Interleukin-4/metabolism , Interleukin-6/biosynthesis , Interleukin-6/immunology , Lipopolysaccharides , Microglia/cytology , Microglia/drug effects , Neutralization Tests , Nitrites/metabolism , Rats , Rats, Wistar , Transforming Growth Factor beta/immunology , Transforming Growth Factor beta/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/immunology
11.
Auton Neurosci ; 85(1-3): 133-40, 2000 Dec 20.
Article in English | MEDLINE | ID: mdl-11189020

ABSTRACT

Vagotomy suppresses fever and hyperalgesia caused by intraperitoneal lipopolysaccharide (LPS) but has little effect on the febrile response to intravenous or intramuscular LPS. This suggests that some vagus-mediated mechanisms are recruited only when LPS is administered via the intraperitoneal route. We hypothesized that such mechanisms are associated with LPS transport from the peritoneal cavity to the circulation. Adult Wistar rats underwent total subdiaphragmatic, bilateral selective celiac, or sham vagotomy. On day 28-32 after surgery, they were injected IP with Escherichia coli LPS (5, 20, or 100 microg/kg) or saline and decapitated 90 min thereafter. Their plasma levels of LPS and their plasma interleukin-6, adrenocorticotropin, and corticosterone responses to LPS were measured. Success of intraperitoneal administration of LPS was verified by increased interleukin-1beta and interleukin-6 concentrations in the peritoneal lavage fluid. Effectiveness of vagotomies was confirmed by increased stomach mass (food retention) and pancreas mass (hypertrophy). In the shams, LPS caused a dose-dependent endotoxemia and increased plasma levels of interleukin-6, adrenocorticotropin, and corticosterone. Neither celiac nor total vagotomy affected any of these responses. LPS escapes from the peritoneal cavity by two primary routes, viz., the hematogenous (via the portal vein) and lymphogenous (via the lymphatic system). The design of the present study did not allow for evaluating the rapid, hematogenous transport. The results obtained suggest that the abdominal vagus does not control the slow. lymphogenous escape of LPS from the peritoneal cavity.


Subject(s)
Lipopolysaccharides/pharmacokinetics , Peritoneal Cavity , Peritoneum/metabolism , Vagus Nerve/physiology , Adrenocorticotropic Hormone/blood , Animals , Ascitic Fluid/chemistry , Ascitic Fluid/metabolism , Corticosterone/blood , Diaphragm , Dose-Response Relationship, Drug , Eating/physiology , Fever/chemically induced , Fever/immunology , Fever/metabolism , Hypertrophy , Interleukin-1/analysis , Interleukin-6/analysis , Interleukin-6/blood , Lipopolysaccharides/blood , Male , Pancreas/pathology , Peritoneum/blood supply , Peritoneum/innervation , Rats , Rats, Wistar , Stomach/physiology , Vagotomy/methods , Vagus Nerve/surgery
12.
J Neurosci ; 19(21): 9579-86, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10531460

ABSTRACT

Repeated treatment with psychostimulant drugs causes long-lasting behavioral sensitization and associated neuroadaptations. Although sensitization induced by a single psychostimulant exposure has also been reported, information on the behavioral and neurochemical consequences of a single psychostimulant exposure is sparse. Therefore, to evaluate whether behavioral sensitization evoked by single and repeated psychostimulant pretreatment regimens represent the same neurobiological phenomenon, the time-dependent expression of behavioral, neurochemical, and neuroendocrine sensitization after a single exposure to amphetamine was investigated in rats. A single exposure to amphetamine (5 mg/kg, i.p.) caused context-independent sensitization of the locomotor effects of amphetamine, which intensified over time. Thus, sensitization to amphetamine was marginal at 3 d after treatment and more evident after 1 week, whereas 3 weeks after treatment, profound sensitization, as well as cross-sensitization, to cocaine was observed. Amphetamine pretreatment caused an increase in the electrically evoked release of [(3)H]dopamine from nucleus accumbens, caudate putamen, and medial prefrontal cortex slices and of [(14)C]acetylcholine from accumbens and caudate slices. The hyperreactivity of dopaminergic nerve terminals appeared to parallel the development of locomotor sensitization, i.e., whereas hyperreactivity of accumbens dopaminergic terminals increased between 3 d and 3 weeks after treatment, the hyperreactivity of medial prefrontal dopaminergic terminals decreased. Pre-exposure to amphetamine also sensitized the hypothalamus-pituitary-adrenal axis response to amphetamine at 1 and 3 weeks, but not at 3 d after treatment. Because these data closely resemble those reported previously for repeated amphetamine pretreatment, it is concluded that a single exposure to amphetamine is sufficient to induce long-term behavioral, neurochemical, and neuroendocrine sensitization in rats.


Subject(s)
Acetylcholine/metabolism , Amphetamine/pharmacology , Caudate Nucleus/physiology , Dopamine/metabolism , Hypothalamo-Hypophyseal System/physiology , Motor Activity/drug effects , Nucleus Accumbens/physiology , Pituitary-Adrenal System/physiology , Prefrontal Cortex/physiology , Putamen/physiology , Adrenocorticotropic Hormone/blood , Adrenocorticotropic Hormone/metabolism , Amphetamine/administration & dosage , Animals , Benzazepines/pharmacology , Carrier Proteins/agonists , Carrier Proteins/physiology , Caudate Nucleus/drug effects , Cocaine/pharmacology , Corticosterone/blood , Corticosterone/metabolism , Dopamine Agonists/pharmacology , Hypothalamo-Hypophyseal System/drug effects , In Vitro Techniques , Injections, Intraperitoneal , Male , Nucleus Accumbens/drug effects , Pituitary-Adrenal System/drug effects , Prefrontal Cortex/drug effects , Putamen/drug effects , Rats , Rats, Wistar , Receptors, Dopamine/physiology , Receptors, Drug/agonists , Receptors, Drug/physiology , Time Factors
14.
J Neuroendocrinol ; 11(7): 513-20, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10444308

ABSTRACT

The present study focuses on the long-term changes in the regulation of the hypothalamic-pituitary-adrenocortical (HPA) axis following two short-lasting episodes of intensive stress in the rat stress model of social defeat and the possible similarities with HPA functioning in human affective disorders. Male Wistar rats experienced social defeats on 2 consecutive days by an aggressive male conspecific. The long-term effect of these defeats on resting and ovine corticotropin-releasing factor (oCRF; intravenous (i.v.) 0. 5 microg/kg) induced levels of plasma ACTH and corticosterone (CORT) were measured 1 and 3 weeks later. In a second experiment the glucocorticoid feedback regulation of HPA function was tested in a combined dexamethasone (DEX)/CRF test (DEX; 25 microg/kg s.c., 90 min before oCRF injection, 0.5 microg/kg). The oCRF challenges were performed between 11.00 and 13.00 h (about three hours after start of the light phase). One week after defeat the ACTH response to CRF was significantly enhanced in defeated rats as compared to controls. Three weeks after defeat the ACTH response was back to control levels. The increased ACTH response 1 week after the stressor was not reflected in higher CORT levels. Neither were baseline ACTH and CORT levels affected by the prior stress exposure. DEX pretreatment inhibited pituitary adrenocortical activity, reflected both in reduced baseline and response values of ACTH and CORT. The ACTH response to CRF following DEX administration was significantly higher in defeated rats as compared to controls both at one and three weeks after defeat. A reduced DEX suppression of baseline secretion of ACTH appeared 3 weeks after defeat. The same tendency was apparent in response and baseline values of CORT. The differences in CORT between socially stressed and control treated rats, however, did not reach significance. The possible role of changes in glucocorticoid-(GR) and mineralocorticoid receptor (MR) binding in the altered regulation of HPA activity following defeat were studied in brain and pituitary of male Wistar rats 1 and 3 weeks after defeat. One week after defeat GR-binding decreased in hippocampus and hypothalamus. No changes were observed in GR-binding in the pituitary nor in MR-binding in any of the regions analysed. Three weeks after defeat GR-binding recovered in hippocampus and hypothalamus but at this time MR-binding in hippocampal tissue was seriously decreased. In a fourth experiment vasopressin (AVP) and CRF stores in the external zone of the median eminence (ZEME) were measured by quantitative immunocytochemistry one and three weeks after defeat and compared with controls. Social defeat failed to induce a change in the immunocytochemical stores of AVP or CRF. The present findings show that in rats short-lasting stressors like defeat induce long-lasting, temporal dynamic changes in the regulation of the HPA axis. Since these changes in time are reflected in GRs and MRs in different brain areas an altered corticosteroid receptor binding might play an important role in the affected HPA activity following defeat.


Subject(s)
Adrenal Cortex/drug effects , Behavior, Animal , Corticotropin-Releasing Hormone/pharmacology , Dexamethasone/pharmacology , Hypothalamo-Hypophyseal System/drug effects , Animals , Arginine Vasopressin/metabolism , Corticotropin-Releasing Hormone/metabolism , Humans , Immunohistochemistry , Male , Median Eminence/metabolism , Protein Binding , Rats , Rats, Wistar , Receptors, Glucocorticoid/metabolism , Receptors, Mineralocorticoid/metabolism , Sheep
15.
Neuroscience ; 92(1): 343-52, 1999.
Article in English | MEDLINE | ID: mdl-10392855

ABSTRACT

Repeated exposure to drugs of abuse induces long-lasting behavioural sensitization, which is thought to play a role in the persistence of drug-seeking behaviour. Recently, we showed that repeated exposure of rats to cocaine resulted in a long-lasting (weeks) sensitization of the hypothalamus-pituitary-adrenal axis, i.e. hypersecretion of adrenocorticotropic hormone and of the glucocorticoid corticosterone. Moreover, we found that the administration of a glucocorticoid receptor antagonist abolished the expression of psychostimulant-induced behavioural sensitization. In the present study we tested whether stressor- or drug-induced long-term hypersecretion of corticosterone is associated with the long-term expression of behavioural sensitization to psychostimulant drugs. To that end, groups of male Wistar rats were exposed once to interleukin-1beta or to footshocks, treatments that are known to induce long-term sensitization of the hypothalamus-pituitary-adrenal axis, or were treated with amphetamine or morphine, according to protocols known to induce long-lasting behavioural (locomotor) sensitization. Three weeks later, the groups and their controls were challenged with amphetamine or vehicle. Previous exposure to interleukin-1beta or footshocks enhanced adrenocorticotropic hormone and corticosterone responses, but did not affect the long-term locomotor sensitization to amphetamine. Prior amphetamine treatment enhanced the locomotor response and the adrenocorticotropic hormone and corticosterone responses to amphetamine. Prior morphine treatment resulted in long-term locomotor sensitization, whereas the adrenocorticotropic hormone and corticosterone responses to amphetamine were decreased. From these findings and the absence of within-group correlation between corticosterone and locomotor responses in interleukin-1beta and morphine-pretreated rats, we conclude that there is no correlation between sensitization of the corticosterone response and behavioural sensitization to amphetamine. Apparently, sensitization of the corticosterone response is not a prerequisite for the long-term expression of behavioural sensitization, which suggests that drug-induced long-term behavioural sensitization may involve corticosteroid receptor-dependent (central) mechanisms that occur independent of hypothalamus-pituitary-adrenal axis responsiveness.


Subject(s)
Amphetamine/pharmacology , Behavior, Animal/drug effects , Corticosterone/metabolism , Interleukin-1/pharmacology , Stress, Physiological/metabolism , Adrenocorticotropic Hormone/blood , Animals , Corticosterone/blood , Electroshock , Male , Morphine/pharmacology , Motor Activity/drug effects , Narcotics/pharmacology , Rats , Rats, Wistar , Time Factors
16.
AIDS ; 13(3): 317-26, 1999 Feb 25.
Article in English | MEDLINE | ID: mdl-10199221

ABSTRACT

OBJECTIVES: To determine the occurrence and cellular localization of inducible nitric oxide synthase (iNOS), NOS activity and its association with cell death in brains of AIDS and AIDS dementia complex (ADC) patients. DESIGN AND METHODS: Post-mortem cerebral cortex tissue of eight AIDS patients, eight ADC patients and eight control subjects was processed for iNOS immunocytochemistry, NADPH-diaphorase activity staining as an index of NOS activity, and in situ end-labelling to detect cell death. RESULTS: iNOS-positive cells were present in the white matter of 14 out of 16 AIDS and ADC patients, whereas two out of eight control subjects showed iNOS-positive cells. iNOS immunoreactivity was exclusively localized in activated macrophages and microglial cells that both showed NADPH-diaphorase activity. In addition, NADPH-diaphorase activity, not related to iNOS immunoreactivity, was observed in astrocytes in both white and grey matter of AIDS and ADC patients. All AIDS and ADC patients, and only one control subject showed characteristic features of apoptotic cell death. CONCLUSIONS: Different forms of NOS are present in microglial cells and astrocytes of AIDS and ADC patients but are largely absent in control subjects. Although more NOS-expressing cells occur in ADC than in AIDS patients, apoptotic cell death was found in both patient groups to the same extent. We postulate that NO production in brains of AIDS patients results in cumulative cortical cell loss, which becomes neurologically evident at later stages of disease and is expressed as ADC.


Subject(s)
AIDS Dementia Complex/physiopathology , Acquired Immunodeficiency Syndrome/physiopathology , Apoptosis , Cerebral Cortex/pathology , Nitric Oxide Synthase/metabolism , AIDS Dementia Complex/pathology , Acquired Immunodeficiency Syndrome/pathology , Adult , Aged , Antibodies, Monoclonal , Autopsy , Cell Death , Cerebral Cortex/virology , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Middle Aged , NADPH Dehydrogenase
17.
J Neurosci ; 19(7): 2799-806, 1999 Apr 01.
Article in English | MEDLINE | ID: mdl-10087091

ABSTRACT

Intraperitoneal administration of the cytokine interleukin-1beta (IL-1beta) induces brain-mediated sickness symptoms that can be blocked by subdiaphragmatic vagotomy. Intraperitoneal IL-1beta also induces expression of the activation marker c-fos in vagal primary afferent neurons, suggesting that IL-1beta is a key component of vagally mediated immune-to-brain communication. The cellular sources of IL-1beta activating the vagus are unknown, but may reside in either blood or in the vagus nerve itself. We assayed IL-1beta protein after intraperitoneal endotoxin [lipopolysaccharide (LPS)] injection in abdominal vagus nerve, using both an ELISA and immunohistochemistry, and in blood plasma using ELISA. IL-1beta levels in abdominal vagus nerve increased by 45 min after LPS administration and were robust by 60 min. Plasma IL-1beta levels increased by 60 min, whereas little IL-1beta was detected in cervical vagus or sciatic nerve. IL-1beta-immunoreactivity (IR) was expressed in dendritic cells and macrophages within connective tissues associated with the abdominal vagus by 45 min after intraperitoneal LPS injection. By 60 min, some immune cells located within the nerve and vagal paraganglia also expressed IL-1beta-IR. Thus, intraperitoneal LPS induced IL-1beta protein within the vagus in a time-frame consistent with signaling of immune activation. These results suggest a novel mechanism by which IL-1beta may serve as a molecular link between the immune system and vagus nerve, and thus the CNS.


Subject(s)
Abdomen/innervation , Interleukin-1/pharmacology , Neuroimmunomodulation , Vagus Nerve/drug effects , Animals , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique , Histocompatibility Antigens Class II/analysis , Immunohistochemistry , Interleukin-1/analysis , Male , Rats , Rats, Sprague-Dawley , Vagus Nerve/cytology , Vagus Nerve/immunology
18.
Am J Physiol ; 276(3): R652-8, 1999 03.
Article in English | MEDLINE | ID: mdl-10070124

ABSTRACT

Interleukin (IL)-6 has been proposed to mediate several sickness responses, including brain-mediated neuroendocrine, temperature, and behavioral changes. However, the exact mechanisms and sites of action of IL-6 are still poorly understood. In the present study, we describe the effects of central administration of species-homologous recombinant rat IL-6 (rrIL-6) on the induction of hypothalamic-pituitary-adrenal (HPA) activity, fever, social investigatory behavior, and immobility. After intracerebroventricular administration of rrIL-6 (50 or 100 ng/rat), rats demonstrated HPA and febrile responses. In contrast, rrIL-6 alone did not induce changes in social investigatory and locomotor behavior at doses of up to 400 ng/rat. Coadministration of rrIL-6 (100 ng/rat) and rrIL-1beta (40 ng/rat), which alone did not affect the behavioral responses, reduced social investigatory behavior and increased the duration of immobility. Compared with rhIL-6, intracerebroventricular administration of rrIL-6 (100 ng/rat) induced higher HPA responses and early-phase febrile responses. This is consistent with a higher potency of rrIL-6, compared with rhIL-6, in the murine B9 bioassay. We conclude that species-homologous rrIL-6 alone can act in the brain to induce HPA and febrile responses, whereas it only reduces social investigatory behavior and locomotor activity in the presence of IL-1beta.


Subject(s)
Behavior, Animal/drug effects , Fever/chemically induced , Hypothalamo-Hypophyseal System/physiology , Interleukin-6/pharmacology , Pituitary-Adrenal System/physiology , Adrenocorticotropic Hormone/blood , Animals , Body Temperature/drug effects , Corticosterone/blood , Humans , Hypothalamo-Hypophyseal System/drug effects , Injections, Intraventricular , Male , Motor Activity/drug effects , Pituitary-Adrenal System/drug effects , Rats , Rats, Wistar , Recombinant Proteins , Social Behavior
19.
Article in English | MEDLINE | ID: mdl-10903812

ABSTRACT

Stress responses play a crucial adaptive role but impose potentially subversive demands on the organism. The same holds for the symptoms of illness as seen after immune activation by pathogens or tissue damage. The responses to immune stimuli and stressors show remarkable similarities and rely on similar control mechanisms in the brain: i.e. they involve neuropeptides of the corticotropin releasing factor (CRF) family. Immune and non-immune challenges lead to responses that normally show a temporal relationship with the duration and intensity of the stimulus and the (re)activity of the stress-responsive systems return to their pre-challenged state within hours or days. However, exposure of animals or man to specific stimuli can induce delayed and long-lasting (weeks, months) alternation in stress responsive systems, resulting in a prolonged period of increased stress vulnerability. Immune stimuli are particularly powerful in eliciting such a stress vulnerable state. Various adaptive changes in the (neuro)biological substrate as seen during this stress vulnerable state also occur in depression, and may be causally related to the depressive symptoms that are often associated with infectious and inflammatory diseases.


Subject(s)
Immune System/physiopathology , Stress, Physiological/physiopathology , Animals , Depression/etiology , Humans , Immune System/physiology , Time Factors
20.
Eur Cytokine Netw ; 9(3): 279-88, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9831177

ABSTRACT

IL-1alpha and IL-1beta have potent effects on the central nervous system resulting in fever, activation of the hypothalamic-pituitary-adrenal axis and behavioural depression. These effects have mainly been studied in rats, using recombinant human and mouse IL-1. Because IL-1alpha and IL-1beta show some species specificity in the potency of their biological activities, the objective of the present work was to directly compare the effects of recombinant rat IL-1alpha and IL-1beta in the rat system as a first step to dissect out the mechanisms that are involved in these effects. In vitro, recombinant rat IL-1alpha and IL-1beta bound with the same affinity as human IL-1 to the rat insulinoma Rin m5F cell line that mainly expresses type I IL-1 receptors. This binding activated IL-1 receptors, as shown by induction of the synthesis of TNF-alpha mRNA. In vivo, recombinant rat IL-1alpha and IL-1beta enhanced body temperature, increased plasma levels of corticosterone and ACTH, and depressed social behaviour. All these effects were obtained at doses 100-1,000 fold lower when IL-1 was injected centrally than when it was administered peripherally, indicating that they are centrally mediated. The relative potencies of recombinant rat IL-1alpha and IL-1beta were not the same depending on the endpoint and the route of injection, indicating that different mechanisms are likely to be involved in the various effects of IL-1 on the brain.


Subject(s)
Body Temperature/drug effects , Brain/drug effects , Cerebral Ventricles/physiology , Interleukin-1/pharmacology , Animals , Brain/physiology , Cerebral Ventricles/drug effects , Cloning, Molecular , Escherichia coli , Exploratory Behavior/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Humans , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/physiology , Injections, Intraventricular , Insulinoma , Interleukin-1/administration & dosage , Interleukin-1/metabolism , Male , Mice , Pancreatic Neoplasms , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/physiology , Rats , Rats, Sprague-Dawley , Receptors, Interleukin-1/physiology , Recombinant Proteins/administration & dosage , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Social Behavior , Transcription, Genetic/drug effects , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...